Search results: Sage Journals

Open accessResearch articleFirst published April, 2026

Correlation of E-cadherin,vimentin,CD206,programmed cell death receptor 1,and programmed cell death ligand 1 expressions with clinicopathological factors and prognosis in oral squamous cell carcinoma

Zheng-Yi Lai, Jie Ma, Jia-Yi Yin [...]

Journal of International Medical Research

Available accessCase reportFirst published January, 2019

Nivolumab-induced aplastic anemia: A case report and literature review

Rachel R Comito, Lynette A Badu, Nicholas Forcello

Journal of Oncology Pharmacy Practice

Open accessReview articleFirst published June, 2022

Tislelizumab: A Modified Anti-tumor Programmed Death Receptor 1 Antibody

Lin Zhang, Zhihua Geng, Bo Hao [...]

Cancer Control

Open accessCase reportFirst published 2022

Cemiplimab for Locally Advanced Cutaneous Squamous Cell Carcinoma: A Case Series of 3 Unique Scenarios

Komal Akhtar, Metlapalli Venkata Sravanthi, Josephine D’Angelo [...]

Journal of Investigative Medicine High Impact Case Reports

Open accessCase reportFirst published September, 2023

Relapse of lupus nephritis induced by nivolumab in an 84-year-old patient with oral cancer: a case report

Zhou Zhou, Qiankun Zhang, Xinbin Wang

Journal of International Medical Research

Available accessResearch articleFirst published January, 2023

Effectiveness and safety of pembrolizumab monotherapy in patients with locally advanced or metastatic non-small-cell lung cancer

Rocio Tamayo-Bermejo, Juan Carlos del Rio-Valencia, Beatriz Mora-Rodriguez [...]

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published 2025

Clinical relevance of circulating tumor DNA in HER2-positive advanced gastric cancer: a collaborative study of a phase Ib trial of dual HER2 and PD-1 targeted therapy (Ni-High)

Hiroki Osumi, Takeru Wakatsuki, Akira Ooki [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2023

Rationale and design of phase II clinical trial of dual inhibition with ramucirumab and erlotinib in EGFR exon 19 deletion-positive treatment-naïve non-small cell lung cancer with high PD-L1 expression (SPIRAL-3D study)

Hayato Kawachi, Tadaaki Yamada, Akihiro Yoshimura [...]

Therapeutic Advances in Medical Oncology

Open accessReview articleFirst published April 29, 2024

PD-1/PD-L1 pathway: Current research in breast cancer

Salman Ardi Syamsu, Muhammad Faruk, Nilam Smaradania [...]

Breast Disease

Open accessReview articleFirst published July 2, 2020

Biomarkers Towards New Era of Therapeutics for Metastatic Renal Cell Carcinoma

Ryuichi Mizuno, Mototsugu Oya

Kidney Cancer

Open accessResearch articleFirst published April, 2026

Correlation of E-cadherin,vimentin,CD206,programmed cell death receptor 1,and programmed cell death ligand 1 expressions with clinicopathological factors and prognosis in oral squamous cell carcinoma

Zheng-Yi Lai, Jie Ma, Jia-Yi Yin [...]

Journal of International Medical Research

Available accessCase reportFirst published January, 2019

Nivolumab-induced aplastic anemia: A case report and literature review

Rachel R Comito, Lynette A Badu, Nicholas Forcello

Journal of Oncology Pharmacy Practice

Open accessReview articleFirst published June, 2022

Tislelizumab: A Modified Anti-tumor Programmed Death Receptor 1 Antibody

Lin Zhang, Zhihua Geng, Bo Hao [...]

Cancer Control

Open accessCase reportFirst published 2022

Cemiplimab for Locally Advanced Cutaneous Squamous Cell Carcinoma: A Case Series of 3 Unique Scenarios

Komal Akhtar, Metlapalli Venkata Sravanthi, Josephine D’Angelo [...]

Journal of Investigative Medicine High Impact Case Reports

Open accessCase reportFirst published September, 2023

Relapse of lupus nephritis induced by nivolumab in an 84-year-old patient with oral cancer: a case report

Zhou Zhou, Qiankun Zhang, Xinbin Wang

Journal of International Medical Research

Available accessResearch articleFirst published January, 2023

Effectiveness and safety of pembrolizumab monotherapy in patients with locally advanced or metastatic non-small-cell lung cancer

Rocio Tamayo-Bermejo, Juan Carlos del Rio-Valencia, Beatriz Mora-Rodriguez [...]

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published 2025

Clinical relevance of circulating tumor DNA in HER2-positive advanced gastric cancer: a collaborative study of a phase Ib trial of dual HER2 and PD-1 targeted therapy (Ni-High)

Hiroki Osumi, Takeru Wakatsuki, Akira Ooki [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2023

Rationale and design of phase II clinical trial of dual inhibition with ramucirumab and erlotinib in EGFR exon 19 deletion-positive treatment-naïve non-small cell lung cancer with high PD-L1 expression (SPIRAL-3D study)

Hayato Kawachi, Tadaaki Yamada, Akihiro Yoshimura [...]

Therapeutic Advances in Medical Oncology

Open accessReview articleFirst published April 29, 2024

PD-1/PD-L1 pathway: Current research in breast cancer

Salman Ardi Syamsu, Muhammad Faruk, Nilam Smaradania [...]

Breast Disease

Open accessReview articleFirst published July 2, 2020

Biomarkers Towards New Era of Therapeutics for Metastatic Renal Cell Carcinoma

Ryuichi Mizuno, Mototsugu Oya

Kidney Cancer